Skip to main content
. 2018 Dec 17;27(1):57–72. doi: 10.1007/s10577-018-9594-z

Fig. 3.

Fig. 3

Reversing repeat instability through CRISPR/Cas9. Can a reduction in the number of rDNA repeats in BLM deficient cells by CRISPR/Cas9-induced breaks rescue clinically relevant features including neurodegeneration, cancer, and aging?